- Home
- PRME vs EHAB Comparison
PRME vs EHAB Comparison
Compare PRME & EHAB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PRME
- EHAB
- Stock Information
- Founded
- PRME 2019
- EHAB 2014
- Country
- PRME United States
- EHAB United States
- Employees
- PRME N/A
- EHAB N/A
- Industry
- PRME Medicinal Chemicals and Botanical Products
- EHAB Hospital/Nursing Management
- Sector
- PRME Health Care
- EHAB Health Care
- Exchange
- PRME Nasdaq
- EHAB Nasdaq
- Market Cap
- PRME 424.9M
- EHAB 397.2M
- IPO Year
- PRME 2022
- EHAB N/A
- Fundamental
- Price
- PRME $4.10
- EHAB $7.89
- Analyst Decision
- PRME Strong Buy
- EHAB Hold
- Analyst Count
- PRME 8
- EHAB 6
- Target Price
- PRME $14.14
- EHAB $9.15
- AVG Volume (30 Days)
- PRME 927.9K
- EHAB 317.4K
- Earning Date
- PRME 11-19-2024
- EHAB 11-06-2024
- Dividend Yield
- PRME N/A
- EHAB N/A
- EPS Growth
- PRME N/A
- EHAB N/A
- EPS
- PRME N/A
- EHAB N/A
- Revenue
- PRME $591,000.00
- EHAB $1,037,200,000.00
- Revenue This Year
- PRME N/A
- EHAB $2.74
- Revenue Next Year
- PRME N/A
- EHAB $3.53
- P/E Ratio
- PRME N/A
- EHAB N/A
- Revenue Growth
- PRME N/A
- EHAB N/A
- 52 Week Low
- PRME $3.28
- EHAB $6.85
- 52 Week High
- PRME $9.86
- EHAB $11.74
- Technical
- Relative Strength Index (RSI)
- PRME 52.64
- EHAB 62.46
- Support Level
- PRME $3.85
- EHAB $7.41
- Resistance Level
- PRME $4.20
- EHAB $8.25
- Average True Range (ATR)
- PRME 0.29
- EHAB 0.25
- MACD
- PRME -0.00
- EHAB 0.13
- Stochastic Oscillator
- PRME 42.42
- EHAB 73.93
About PRME Prime Medicine Inc.
Prime Medicine Inc is a biotechnology company committed to delivering genetic therapies to address diseases by deploying gene editing technology, Prime Editing. The Prime Editing technology is a next-generation technology that can search and replace to restore normal genetic function in the genome and can treat a wide spectrum of diseases with high unmet medical needs and efficient and broad gene editing technology.
About EHAB Enhabit Inc.
Enhabit Inc provides home health and hospice services in the United States. It offers care where patients prefer it: in their homes. It operates business in two segments: home health and hospice. Its home health segment include a comprehensive range of Medicare-certified home nursing services to adult patients in need of care. These services include, among others, skilled nursing, physical, occupational, and speech therapy, medical social work, and home health aide services. The hospice segment focuses on the quality of life for patients who are experiencing an advanced, life-limiting illness while treating the person and symptoms of the disease, rather than the disease itself. The company generates the majority of its revenue from the Home Health segment.